Mr Rajeev Nannapaneni, Chief Operating Officer of Natco Pharma Ltd, has been elevated to the position of Vice-Chairman and Chief Executive Officer of the company.
Mr Rajiv, who joined the Hyderabad-based company’s board in 2005, would be in-charge of all day-to-day operations and oversee all functional areas, Nacto said in a release issued here on Thursday.
Mr Rajeev was instrumental in Natco obtaining the first-ever compulsory licence in India for the generic version of Bayer’s Nexavar, a drug used in the treatment of kidney and liver cancers, it added.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.